GlaxoSmithKline is cutting a further 200 jobs at a factory in north-east England that makes its anti-nausea drug Zofran, a spokeswoman for the world's second biggest drugmaker said on Wednesday.

R&D company Newron Pharmaceuticals SpA announced December 3, it has entered into an equity funding agreement with YA Global Investments to raise up to 30 million Swiss francs.

The European Commission today, December 12, extended its review of Israeli drugmaker Teva Pharmaceutical's bid to acquire U.S. biopharmaceutical and generic drugs marketer Barr Pharmaceuticals Inc.

The prospects of Swiss drugmaker Roche raising a $45 billion (29.3 billion pound) syndicated loan to finance the buyout of the rest of U.S. biotech group Genentech are becoming increasingly remote.

Goldshield Group plc said on Friday, November 28, half-year revenues increased by 23 percent, after strong growth in its pharmaceutical and consumer health products units.

Assura Group Ltd, the UK's biggest private owner of GP services, said first-half turnover rose to £22.3 million, driven by rental growth and increased revenues from wholly owned pharmacies.

Roche Holding's lung cancer drug Tarceva has won final approval for use by the National Health Service (NHS) after the Swiss drugmaker agreed to discount the price of the medicine.

Imperial Tobacco posted annual earnings towards the top end of forecasts, helped by cash-strapped smokers switching to its cheaper brands and the smooth integration of its purchase of rival Altadis.

Drugmakers face being hauled over the coals this week when the European Commission unveils the results of a broad inquiry into possible anti-competitive behaviour in the industry.

The UK's biggest care home operator Southern Cross said it had appointed Jamie Buchan as its new chief executive, having led the turnaround of the ExCeL exhibition centre in London.

Drugmaker Roche Holding AG said Monday, November 24, its breast cancer drug Avastin met its primary endpoint in a Phase III breast cancer trial.

The pharmaceutical sector supplier has reported pre-tax profits of €66.2 million in the period to September 30, an increase of 17 percent.

Anglo-Swedish drugmaker AstraZeneca plans 1,400 job cuts and is closing three plants around Europe as it joins others in the sector tackling increased competition and cost pressures.

Elan Corp plc, the Dublin-based drug company, has appointed Carlos V Paya as President, effective November 25.

Anglo-Swedish drugmaker AstraZeneca saw shares plummet 11 percent on Wednesday after it said its full-year earnings per share (EPS) would be at the lower end of its previously stated range.

Dublin-based United Drug plc has acquired the entire issued share capital of The Specials Laboratory Holdings Ltd (TSL) for a consideration of £20.1 million.

Drugmaker Merck KGaA, which markets Genentech’s psoriasis drug Raptiva, has said it is working with European Union regulators following the death of a second patient.

Consumer goods giant Unilever dealt a blow to drugs-from-plants firm Phytopharm on Friday by abandoning plans to develop its Hoodia product as a functional food to help people lose weight.

Pfizer Inc, the world’s largest drug company has announced plans to spend up to US$60 million (£41 million) on a research centre in Cambridge.

Roche Holding AG has stated that its drug Avastin extended the lives of patients with one of the most common types of lung cancer by four months.

GlaxoSmithKline, Europe's largest drugmaker, has increased its stake in Addex Pharmaceuticals to five percent, the biotechnology firm said on Wednesday, November 12.

GlaxoSmithKline , the world's second biggest drugmaker, said on Tuesday it planned to close its Dartford manufacturing site in south-east England by 2013 with the loss of 620 jobs.

Swiss dental implant maker Nobel Biocare said this morning, November 11, it is buying privately-owned prosthetics software design company BioCad for €26 million.

A large-scale study of AstraZeneca plc's anti-cholesterol drug, Crestor, has been shown to cut heart-attack risk even for people without high cholesterol, the drugmaker said.

Swiss drugmaker Roche said today, November 7, a Phase III study has confirmed that its drug Tarceva delays the advance of lung cancer when given immediately after chemotherapy.

Europe's biggest medical device company Smith & Nephew posted third-quarter earnings short of analyst forecasts on Thursday and suspended share buybacks, sending its stock sharply lower.

French drugmaker Sanofi-Aventis announced yesterday, November 5, it would discontinue all clinical trials involving its troubled anti-obesity pill Acomplia.

GlaxoSmithKline , the world's second-biggest drugmaker, is cutting approximately 1,000 U.S. sales jobs by the end of 2008 as it reorganises the operation to compete in an increasingly tough market.